Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...

DFE Pharma has launched its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in ...

The pharmaceutical manufacturing market is poised for growth by leveraging advanced technologies, digital platforms, and robust supply chain strategies. Opportunities arise in adopting ...

Ipca remains on a robust growth path in domestic formulation segment, as the company not only delivered healthy double-digit ...

India, Feb. 16 -- A pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services has come into the spotlight after ...

After struggling through the 1990s, Desh Bandhu Gupta, founder of pharma company Lupin, set out a clear strategy for growth ...

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are ...

The pharmaceutical sector continues to witness earnings-driven momentum as companies report resilient Q3 FY26 performance, supported by strong domestic demand, export traction, and improved ...

Welcome to the PharmTech Weekly Roundup, your briefing on the latest developments in pharmaceutical manufacturing and development for the week of February 9, 2026. I’m your host, associate editorial ...

Under the collaboration, Phlow will produce the U.S.-based API, while Fresenius Kabi will manufacture the finished doses for ...

Earnings before interest, tax, depreciation and amortisation (EBITDA) surged to ₹158.7 crore in Q3 FY26, up from ₹39 crore in ...

Opinion: Freedom-to-operate analysis must be understood as a continuous, integrated process that evolves alongside science, regulation, and commercial strategy.